FDA Requests Manufacturers Of Ranitidine (Zantac) To Immediately Remove All Such Products From U.S. Market
On April 1, 2020, the FDA requested manufacturers of ranitidine (Zantaxc) to immediately withdraw all prescription and over-the-counter ranitidine products from the U.S. market due to a contaminant known as N-Nitrosodimethylamine (NDMA) found in the medicines. The FDA determined that NDMA in some ra[...]